FEB 26, 2015 08:39 AM PST

New Clues for Treatment of Antibiotic-Resistant Bacteria

WRITTEN BY: Judy O'Rourke
Researchers at the University of Georgia have identified a previously unknown process that many bacteria, including those that cause disease in humans, use to survive. Their discovery could lead to new therapies for bacterial infections like MRSA and tuberculosis that are resistant to current antibiotic treatments.

Their discovery centers on the ways in which bacteria use an iron compound known as heme. Most commonly recognized as a fundamental component of hemoglobin-the red pigment in blood responsible for the transportation of oxygen-heme also provides some of the essential nutrition that bacteria require to grow within a host.
"We found an enzyme that only gram-positive bacteria have, and they use this enzyme in a unique way to make heme," says Harry Dailey, PhD, professor of microbiology and lead author of the paper describing their discovery in the Proceedings of the National Academy of Sciences. "Heme is essential for these organisms; they have to make heme, so if we can find a way to disrupt this process, the bacteria would die."

More than 2 million people become infected with bacteria that are resistant to antibiotics each year in the United States, and at least 23,000 people die as a direct result of these infections, according to the Centers for Disease Control and Prevention.

The enzyme discovered in Dailey's lab could serve as an attractive target for the next generation of antibacterial drugs, and his laboratory is partnered with other institutions to explore the development of new therapeutics.

"One of the great things about this enzyme in terms of treatment is that it is only found in gram positive bacteria-it's not found anywhere else," says Dailey, who's also director of UGA's Biomedical and Health Sciences Institute. "So if you target the enzyme with a therapeutic, you won't damage any of the other essential mechanisms that we need to remain healthy."

Their discovery also challenges some of the established scientific literature related to the production of heme, which has remained largely unchanged for decades.

"We are obviously very excited about the potential medical applications related to this enzyme, but our experiments also tell us a lot about the evolutionary history driving the behavior of organisms we study every day," Dailey says. "We have assumed for more than 50 years that we understood these pathways well, but it may not be as clear cut as we once thought."

A version of the paper as it appeared in PNAS is titled "Noncanonical coproporphyrin-dependent bacterial heme biosynthesis pathway that does not use protoporphyrin."

[Source: University of Georgia]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
OCT 20, 2019
OCT 20, 2019
The Right Cocktail of Gut Microbes may Prevent or Reverse Food Allergies
Food allergies are a growing public health concern. New work may help pave the way for a therapeutic that reduces or stops allergies....
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
DNA Analysis Shows How Algae Respond to a Changing Environment
While a type of algae appears to be thriving in the face of its downgraded envrionment, the story is turning out to be more complex....
OCT 20, 2019
Health & Medicine
OCT 20, 2019
Acute Flaccid Myelitis and Its Association With Enterovirus D68
Acute flaccid myelitis (AFM), a polio-like infection, caught the attention of physicians in the U.S. during late summer and early fall in 2014. The outbrea...
OCT 20, 2019
Earth & The Environment
OCT 20, 2019
The methane-eating microorganisms in the ocean
New research published in the journal Limnology and Oceanography reveals part of the mystery behind a one million square kilometer patch of ocean in the Pa...
OCT 20, 2019
OCT 20, 2019
Alzheimer's to be Diagnosed from Pupil Dilation
Researchers from the University of California have found a low-cost, non-invasive method to aid in diagnosing Alzheimer’s Disease (AD) before cogniti...
OCT 20, 2019
Drug Discovery & Development
OCT 20, 2019
Nanomesh Development Advances Drug Delivery's Fight Against Antibiotic-Resistance
As concern over medication-resistant bacteria grows, researchers at Flinders University have now fabricated nanomeshes as an effective drug delivery method...
Loading Comments...